Cigna Corp (NYSE:CI) has received a consensus recommendation of “Buy” from the twenty ratings firms that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and sixteen have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $237.05.

Several research firms recently commented on CI. Mizuho boosted their price target on Cigna from $180.00 to $205.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Citigroup upped their target price on Cigna from $221.00 to $263.00 and gave the company a “buy” rating in a research report on Thursday, January 23rd. Deutsche Bank upped their target price on Cigna from $210.00 to $229.00 and gave the company a “buy” rating in a research report on Thursday, December 19th. Raymond James upped their target price on Cigna from $225.00 to $240.00 and gave the company an “outperform” rating in a research report on Friday, February 7th. Finally, Evercore ISI initiated coverage on Cigna in a research report on Friday, February 7th. They issued a “hold” rating and a $230.00 target price on the stock.

In related news, insider Timothy C. Wentworth sold 12,436 shares of the company’s stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $199.15, for a total transaction of $2,476,629.40. Following the completion of the transaction, the insider now directly owns 108,214 shares in the company, valued at approximately $21,550,818.10. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director John Partridge sold 3,300 shares of the company’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $203.70, for a total value of $672,210.00. Following the transaction, the director now owns 29,180 shares of the company’s stock, valued at $5,943,966. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,545 shares of company stock worth $10,612,704. Corporate insiders own 0.80% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Metropolitan Life Insurance Co NY grew its stake in shares of Cigna by 0.6% in the third quarter. Metropolitan Life Insurance Co NY now owns 62,130 shares of the health services provider’s stock worth $9,431,000 after purchasing an additional 380 shares in the last quarter. Factory Mutual Insurance Co. boosted its stake in Cigna by 54.6% during the fourth quarter. Factory Mutual Insurance Co. now owns 141,500 shares of the health services provider’s stock valued at $28,935,000 after buying an additional 50,000 shares in the last quarter. Cornerstone Advisors Inc. boosted its stake in Cigna by 6.2% during the fourth quarter. Cornerstone Advisors Inc. now owns 1,343 shares of the health services provider’s stock valued at $275,000 after buying an additional 78 shares in the last quarter. Moon Capital Management LLC boosted its stake in Cigna by 1.3% during the fourth quarter. Moon Capital Management LLC now owns 23,068 shares of the health services provider’s stock valued at $4,717,000 after buying an additional 295 shares in the last quarter. Finally, Cognios Capital LLC bought a new position in Cigna during the third quarter valued at about $269,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Shares of NYSE:CI traded down $1.55 during trading on Friday, reaching $220.34. 2,077,300 shares of the stock were exchanged, compared to its average volume of 1,866,903. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.63 and a current ratio of 0.43. Cigna has a 12-month low of $141.95 and a 12-month high of $224.64. The firm has a market cap of $78.54 billion, a price-to-earnings ratio of 16.41, a price-to-earnings-growth ratio of 1.00 and a beta of 0.79. The firm’s 50-day moving average price is $206.20 and its 200 day moving average price is $181.01.

Cigna (NYSE:CI) last issued its earnings results on Thursday, February 6th. The health services provider reported $4.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.20 by $0.11. The business had revenue of $36.54 billion during the quarter, compared to analysts’ expectations of $35.20 billion. Cigna had a return on equity of 14.69% and a net margin of 3.32%. The company’s revenue for the quarter was up 165.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.46 EPS. As a group, equities research analysts forecast that Cigna will post 18.51 EPS for the current year.

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Recommended Story: What is the definition of arbitrage?

Analyst Recommendations for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.